
### [Orphanet:206953](http://www.orpha.net/ORDO/Orphanet_206953)
**Label:** Muscular lipidosis

**Subclasses:** [Orphanet:99846](http://www.orpha.net/ORDO/Orphanet_99846) (Autosomal dominant myoglobinuria), [Orphanet:99845](http://www.orpha.net/ORDO/Orphanet_99845) (Genetic recurrent myoglobinuria), [Orphanet:26793](http://www.orpha.net/ORDO/Orphanet_26793) (Very long chain acyl-CoA dehydrogenase deficiency), [Orphanet:26792](http://www.orpha.net/ORDO/Orphanet_26792) (Short chain acyl-CoA dehydrogenase deficiency), [Orphanet:26791](http://www.orpha.net/ORDO/Orphanet_26791) (Multiple acyl-CoA dehydrogenase deficiency), [Orphanet:2596](http://www.orpha.net/ORDO/Orphanet_2596) (Myopathy and diabetes mellitus), [Orphanet:157](http://www.orpha.net/ORDO/Orphanet_157) (Carnitine palmitoyltransferase II deficiency), [Orphanet:158](http://www.orpha.net/ORDO/Orphanet_158) (Systemic primary carnitine deficiency), 

**Corr. equiv. classes:** [Orphanet:26792](http://www.orpha.net/ORDO/Orphanet_26792), [Orphanet:26793](http://www.orpha.net/ORDO/Orphanet_26793), [OMIM:268200](http://purl.obolibrary.org/obo/OMIM_268200), [Orphanet:157](http://www.orpha.net/ORDO/Orphanet_157), [OMIM:160010](http://purl.obolibrary.org/obo/OMIM_160010), [OMIM:608836](http://purl.obolibrary.org/obo/OMIM_608836), [OMIM:201475](http://purl.obolibrary.org/obo/OMIM_201475), [OMIM:500002](http://purl.obolibrary.org/obo/OMIM_500002), [OMIM:201470](http://purl.obolibrary.org/obo/OMIM_201470), [Orphanet:26791](http://www.orpha.net/ORDO/Orphanet_26791), [OMIM:600649](http://purl.obolibrary.org/obo/OMIM_600649), [OMIM:255110](http://purl.obolibrary.org/obo/OMIM_255110), [Orphanet:99845](http://www.orpha.net/ORDO/Orphanet_99845), [OMIM:550500](http://purl.obolibrary.org/obo/OMIM_550500), [Orphanet:99846](http://www.orpha.net/ORDO/Orphanet_99846), [Orphanet:2596](http://www.orpha.net/ORDO/Orphanet_2596), [OMIM:212140](http://purl.obolibrary.org/obo/OMIM_212140), [Orphanet:158](http://www.orpha.net/ORDO/Orphanet_158), [OMIM:231680](http://purl.obolibrary.org/obo/OMIM_231680), 

**Class expressions from DL-Learner:**

- [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 48.51%
- [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 48.51%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) 48.51%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 48.51%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) 48.51%
- [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 48.51%
- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 48.51%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 48.51%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 48.51%
- [HP:0001392](http://purl.obolibrary.org/obo/HP_0001392) (Abnormality of the liver) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 48.51%
- [HP:0001392](http://purl.obolibrary.org/obo/HP_0001392) (Abnormality of the liver) and [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 48.51%
- [HP:0002913](http://purl.obolibrary.org/obo/HP_0002913) (Myoglobinuria) and (not ([HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier))) 46.87%
- [HP:0002913](http://purl.obolibrary.org/obo/HP_0002913) (Myoglobinuria) and (not ([HP:0004302](http://purl.obolibrary.org/obo/HP_0004302) (Functional motor problems))) 46.87%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) 45.43%
- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0004359](http://purl.obolibrary.org/obo/HP_0004359) (Abnormality of fatty-acid metabolism) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) 44.17%


